Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial.

Autor: Rebelatto, Carmen Lúcia Kuniyoshi1,2,3 (AUTHOR) carmen.rebelatto@pucpr.br, Senegaglia, Alexandra Cristina1,2,3 (AUTHOR), Franck, Claudio Luciano2 (AUTHOR), Daga, Debora Regina1,3 (AUTHOR), Shigunov, Patrícia3,4 (AUTHOR), Stimamiglio, Marco Augusto3,4 (AUTHOR), Marsaro, Daniela Boscaro1,3 (AUTHOR), Schaidt, Bruna1 (AUTHOR), Micosky, Andressa1 (AUTHOR), de Azambuja, Ana Paula2 (AUTHOR), Leitão, Cleverson Alex2 (AUTHOR), Petterle, Ricardo Rasmussen5 (AUTHOR), Jamur, Valderez Ravaglio1 (AUTHOR), Vaz, Isadora May1 (AUTHOR), Mallmann, Antônio Paulo6 (AUTHOR), Carraro Junior, Hipólito2 (AUTHOR), Ditzel, Eduardo7 (AUTHOR), Brofman, Paulo Roberto Slud1,3 (AUTHOR), Correa, Alejandro3,4 (AUTHOR)
Zdroj: Stem Cell Research & Therapy. 3/21/2022, Vol. 13 Issue 1, p1-22. 22p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje